S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

UTHR United Therapeutics Corporation

262.40

4.27 (1.65%)

May 03 2024 - Closed

Delayed by 15 minutes

FDA grants accelerated review to United Therapeutics' Tyvaso DPI application

To read the full story on Seeking Alpha, click here.

United Therapeutics (NASDAQ:UTHR)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more United Therapeutics Charts.

United Therapeutics (NASDAQ:UTHR)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more United Therapeutics Charts.

United Therapeutics Corporation News

United Therapeutics Corporation Reports First Quarter 2024 Financial Results
Wednesday 1 May 2024 (4 days ago) • Business Wire

CORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney Transplant
Friday 26 April 2024 (1 week ago) • Business Wire

United Therapeutics Announces World’s First Successful Xenothymokidney Transplant
Wednesday 24 April 2024 (2 weeks ago) • Business Wire

United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024
Wednesday 24 April 2024 (2 weeks ago) • Business Wire

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference
Tuesday 16 April 2024 (3 weeks ago) • Business Wire

United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation
Tuesday 26 March 2024 (1 month ago) • Business Wire

United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program
Monday 25 March 2024 (1 month ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

More United Therapeutics Corporation News Articles

Code Green Apparel (PK)

Kraig Biocraft Laborator... (QB)

1812 Brewing (PK)

Voip Pal Com (QB)

AMC Entertainment

Trump Media and Technology

Digital Brand Media and ... (PK)

Rennova Health (PK)

Anavex Life Sciences

Asia Broadband (PK)

Northwest Biotherapeutics (QB)

Impact Fusion (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions